Brentuximab Intravenous and Loteprednol and Tobramycin
Determining the interaction of Brentuximab Intravenous and Loteprednol and Tobramycin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab Intravenous-Loteprednol and tobramycin ophthalmic
- Brentuximab Intravenous-Loteprednol Etabonate
- Brentuximab Intravenous-Loteprednol Eye Drops
- Brentuximab Intravenous-Loteprednol Eye Drops 0.2%
- Brentuximab Intravenous-Loteprednol Eye Drops 0.5% and 1%
- Brentuximab Intravenous-Loteprednol Eye Gel
- Loteprednol and Tobramycin-Brentuximab vedotin
- Loteprednol and Tobramycin-Breo Ellipta
- Loteprednol and Tobramycin-Brethine
- Loteprednol and Tobramycin-Brethine Subcutaneous
- Loteprednol and Tobramycin-Bretylium
- Loteprednol and Tobramycin-Bretylium Injection